European Medicines Agency (EMEA). Assessment report for Bridion.《http://www.emea.europa.eu/humandocs/PDFs/EPAR/bridion/H-885-en6.pdf》
Craig RG, Hunter JM. Neuromuscular blocking drugs and their antagonists in patients with organ disease. Anaesthesia 2009; 64 (Suppl. 1): 55-65.
European Medicines Agency (EMEA). Bridion (sugammadex sodium) 100mg/mL: summary of product characteristics.《http://www.emea.europa.eu/humandocs/PDFs/EPAR/bridion/H-885-PI-en.pdf》
Yang LPH, Keam SJ. Sugammadex: a review of its use in anaesthetic practice. Drugs 2009; 69: 919-42.
Staals LM, Snoeck MMJ, Driessen JJ, et al. Multicentre, parallel-group, comparative trial evaluating the efficacy and safety of sugammadex in patients with end-stage renal failure or normal renal function. Br J Anaesth 2008; 101: 492-7.